Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5

Glycoconjugate vaccines based on isolated capsular polysaccharide (CPS) save millions of lives annually by preventing invasive pneumococcal disease caused by Streptococcus pneumoniae. Some components of the S. pneumoniae glycoconjugate vaccine Prevnar13 that contains CPS antigens from 13 serotypes u...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Proc Natl Acad Sci U S A
Asıl Yazarlar: Lisboa, Marilda P., Khan, Naeem, Martin, Christopher, Xu, Fei-Fei, Reppe, Katrin, Geissner, Andreas, Govindan, Subramanian, Witzenrath, Martin, Pereira, Claney L., Seeberger, Peter H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: National Academy of Sciences 2017
Konular:
Physical Sciences
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5651752/
https://ncbi.nlm.nih.gov/pubmed/28973947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1706875114
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller